Cosmeceuticals Market to be Driven by Increased Desire of Consumers to Maintain Youthful Appearance

Developed economies with a high population are considered to be high-potential markets for cosmeceutical brands. People in the present generation are becoming conscious about their looks and thus are ready to spend extensively to maintain a youthful appearance by consuming or applying cosmeceutical products. The emergence of a well-heeled middle class bearing a taste for luxurious products in nations such as India, Brazil, China, and Russia is anticipated to boost the demand for cosmeceuticals throughout the forecast period.

On the basis of product type, the global cosmeceuticals market is divided into cosmetics and toiletries, tissue fillers, age-defying products, lip care products, hair care products, skin care products, and injectable cosmeceuticals. Among these products, anti-aging creams bear high potential in the near future. According to the chemical used in the product, this market is further classified into antioxidants, proteins, alpha hydroxy acids, botanicals, and enzymes. Among these, antioxidants are expected remain the strongest in this market in the coming years.

The research report on the global cosmeceuticals market is further segmented on the basis of geography into Asia Pacific, North America, Europe, and Rest of the World. The cosmeceuticals market is expected to witness steady but moderate growth in the developed nations of North America and Europe. On the flip side, the Asia Pacific cosmeceuticals market is expected to expand rapidly in the near future.

In developed European countries such as France, the United Kingdom, the Netherlands, Germany, and others, the obsession for looking young is one of the greatest growth drivers. The comparatively high per capita income in these nations allows the consumers to spend generously on cosmeceuticals. In addition, marketing activities carried out by several cosmeceutical companies are majorly concentrated in the U.S. and Europe. Cosmeceutical companies are majorly gaining traction in Asia Pacific, where the booming e-commerce industry has provided consumers with simple access to cosmeceutical brands across the globe. 

Get a PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=268

Furthermore, the research report talks about the competitive landscape of the global cosmeceuticals market, including the company profiles, business strategies, and recent developments in the industry. Some of the prominent players operating in the global cosmeceuticals market are BASF SE, Croda International, Colgate-Palmolive, Arch Chemicals, Unilever Group, Allergan Inc., and Procter & Gamble. Many other companies are expanding their horizons to enjoy competitive advantage in this market.

Future of Telemedicine - Key Trends and Forecast 2020

Telemedicine is the evolved format of traditional medicine that provides medical care to millions of individuals worldwide with the benefits of cost efficiency and convenience of location. The basic difference between traditional healthcare technology and telemedicine is the use of telecommunication technology to provide patients and medical practitioners the convenience of location, cost and time. With the advent of communication technology in medical sciences, telemedicine revolutionized the overall framework of healthcare. Patients were no longer subjected to travel or waiting periods and could seek medical attention at the comfort of their homes. This greatly changed the perception of medical practice, which is the major reason why telemedicine is currently considered synonymous with general medicine. Telemedicine involves the use of mobile communication technology and image/video transfer technology via the internet. The internet has provided the basis for information exchange, which is stored and maintained by the servers present at either hospitals or telemedicine service provider company at a nominal cost. 

Current Developments in the Global Telemedicine Market

At present, the global telemedicine technologies market is facing a number of challenges that it needs to overcome in order to ensure its high growth in the coming few years. Some of the major challenges hampering this market are the shortage of skilled and experienced professionals in remote areas and absence of consumer awareness about telemedicine technologies and their uses. Other major restraints suppressing the global telemedicine technologies market are the lack of proper insurance and strict regulatory framework governing this industry.

Currently, North America and Europe are leading the global telemedicine technologies market. This is due to the elevated acceptance of telemedicine technologies in these regions. In addition to this, the presence of enhanced healthcare and IT infrastructure promotes the adoption of telemedicine technologies.

Expected Developments in the Global Telemedicine Market

The global telemedicine technologies market is expected to grow at a double-digit CAGR during the forecast period of 2010 to 2017. In the coming few years, the improved access to patient care and telehealth technologies reaching new markets is expected to propel the market. Furthermore, with the advent of telemedicine technologies, the number of emergency room visits and hospitalization is expected to reduce drastically. Multiple healthcare providers can communicate with an individual episode of care and centralize all the existing data and streamline data collection via telemedicine technologies. This is expected to reduce the gap between clinician supply and patient demand.

According to market analysts, China, Brazil, India, and Russia will experience a high growth rate in the global telemedicine technologies market in the coming few years. These regions will benefit from their expanding populations and the accelerating incidence of chronic diseases such as asthma, diabetes, and heart failure. Furthermore, increasing healthcare costs and rising awareness of telemedicine in remote locations will also drive these markets.

Get a Sample Copy of the Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

Key players in the global telemedicine technologies market are thus focusing on the emerging markets of Russia and Brazil to expand their services. The global telemedicine technologies market is broadly segmented into software, hardware, and services. Some of the most prominent companies in the global telemedicine technologies market are AMD Telemedicine, McKesson Ltd., Philips Healthcare, GE Healthcare, and Cardio Net.

How Social Media and Big Data Aid Healthcare?

The rate of technological progression over the past few decades has been astounding, so much so that computing technology is finding it tough to keep up with Moore’s Law. Gordon E. Moore, in 1965, made a rough calculation that the number of transistors that a chip holds will double every two years, thanks to consistent demand for progressively advanced products. We are now at a point where standard silicon-technology-based chips are finding it tough to cram themselves with additional transistors. So while the advent of better forms of chip-making emerge, the point is clear that we’ve come a long way in a very short time. This only makes it logical that healthcare, one of the essential industries for mankind, uses what’s at the forefront of the technology of its generation. On top of the list for this generation is the barrage of social media data we put out into the world.

Get a PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5807

Tweeting for Better Health

In May 2011, researchers from the University of Iowa figured out a way to use Twitter to track diseases in terms of their level of reach and activity in the U.S. The studies were conducted during the influenza A H1N1 pandemic. The published report shows that the team of three scientists was able to successfully use Twitter to check the developments in public sentiment during the spread of swine flu. In addition to this, they also managed to measure the level of activity of the disease through tweets from different regions. The report conclusively showed that social media platforms, especially Twitter, can be easily used to track public concerns over health and thus gauge the spread of diseases.

And the Twitter train doesn’t stop at contagious diseases and pandemics, either. In early 2015, University of Pennsylvania researchers stated that they can correlate region-based data on heart disease to a higher rate of negative Tweets. The researchers compared the data published by the CDC and the general emotional quotient of tweets from various regions. They found that there was a direct proportion between the number of emotionally negative tweets and the prevalence of coronary heart diseases. Of course, we need to remember that correlation does not imply causation – just because one sends negative Tweets does not mean they have heart disease. But it is data like this that can lead to a more concrete analysis for a better healthcare structure.

Big Data and Predictive Healthcare

The global healthcare industry is taking its next big step already: healthcare is on its way to becoming more proactive than reactive. What this means is the incorporation of intuitive technology that will anticipate patient problems before they happen, based on previously collected data. While this could practically spell out miracles for patients, we are still a long way from creating the perfect predictive healthcare system. But as a starting point, we have the currently trending big data business.

Big data can work better with healthcare to make it more intuitive. For instance, the piles of data gathered from one person regarding his/her eating habits, workout routines or lack of exercise, and sleeping habits, can be vital in telling whether that person is susceptible to diseases or not. With big data analytics, this can be performed efficiently for a large population. The health records can even span across generations of a family, enabling medical knowledge of genetic traits that might show up in new generations.

There are many other tech trends that can be extremely helpful in the field of medicine; many of them already are: improved sensory tech and better materials are being used in performing delicate surgeries and creating state-of-the-art prosthetics. Doctors all over the world are making the most out of the Internet and high-speed data transmission to create live global lecture halls where veterans perform surgeries in their OR while the others watch on their screens and learn. Indeed, we have come a long way from non-sterilized amputations and witch doctors, and into concepts that, ironically, seem more and more like magic.

Medical Devices Outsourcing Market to Expand at 11.6% CAGR till 2018 owing to Increasing Demand for Quality Healthcare Services

Medical devices outsourcing refers to the process of medical device manufacturers hiring third-party members for the completion of business-related functions such as product designing, upgrading, maintenance, and testing. Outsourcing such activities allows medical device manufacturers to focus solely on its core competencies and leave the rest to third party professionals. 

Leading manufacturers in the medical device industry are opting for outsourcing solutions to not only manage their device manufacturing processes but also to cut costs and use saved resources for technical and clinical innovations. Medical devices outsourcing has emerged as a practical and cost-effective solution in various disciplines of medicine including orthopedics, cardiovascular, anesthesiology, radiology, and neurology. 

Product Outsourcing a Rising Trend in Recent Times 

According to a report published by Transparency Market Research, the global medical devices outsourcing market is projected to develop at a CAGR of 11.6% from 2012 to 2018, rising from a value of US$21.1 billion in 2012 to US$40.8 billion by 2018. 

This growth in the medical devices outsourcing market can be attributed to the growing demand for quality healthcare services and significant developments in the field of medical technology. Looking to cut costs and attain sustainability in the long run, more and more players are opting to outsource parallel operations to smaller and more specialized service providers. Functions that were once performed by in-house teams within healthcare companies are now being taken care of by external sources on a project-based routine.  

Product Design Services Most Highly Outsourced Medical Device Service  

On the basis of application, the medical devices outsourcing market is categorized into Class I, Class II, and Class III medical devices. Of these, Class II devices held the largest share of the overall market owing to moderate related risks and limited regulatory requirements. On the basis of service, medical device outsourcing includes product implementation services, product design and development services, product upgrade services, regulatory consulting services, product maintenance services, and product testing services. Rising challenges in manufacturing as well as technical cost containment have made product design services the most frequently outsourced service. This segment held a share of 29% in 2012, making it the largest service segment of the medical devices outsourcing market. 

Driven by Rising Healthcare Costs, North America Emerges Leader in Medical Devices Outsourcing Market  

The global medical devices outsourcing market comprises four main regions: North America, Europe, Asia Pacifica, and Rest of the World. Surging healthcare costs have enabled North America to emerge as the leading regional market for medical devices outsourcing. In addition, increasing number of medical insurance providers and their expanding coverage in the region has resulted in the growing demand for quality healthcare services, thereby forcing industry players to resort to medical devices outsourcing. Asia Pacific, on the other hand, has been identified as an immensely lucrative market for medical devices outsourcing given the region’s recent potential to attract foreign investors. 

The prominent players functioning in the global medical devices outsourcing market include Micro Systems Engineering GmbH, Accellent Inc., Cirtec Medical Systems LLC., Active Implants Corporation, Avail Medical Product, Creganna-Tactx Medical, and Mdmi Technologies Inc. 

For complimentary access to more information on this research, please visit: http://www.transparencymarketresearch.com/medical-devices-outsourcing-market.html

Nanoclay Reinforcement Market will Continue to Grow Strongly Through 2023

Application of organo-modified montmorillonite (MMT), also known as “Nanoclay,” in the reinforcement of polymer-based composites has managed to attract a lot of attention from the industrial sectors. Addition of tiny amounts of nanoclay significantly augments the mechanical properties of pristine polymers. Nanoclay reinforcements are utilized in various applications for the enhancement of mechanical, thermal, and electrical properties. This includes hybrid phenolic friction composites, medium density fiberboard (MDF), liquid silicone rubber, fibers, polymer films, nonwovens, and other composite materials. MDF is wood-based composite used primarily in the furniture industry. Nanoclay reinforcement has found an extensive application base across various industries including adhesives, cable inks, coatings, pharmaceuticals, and automotives.

Nanoclay reinforcements is anticipated to grow into one of the most attractive segments in the nanotechnology market due to low manufacturing cost and ready availability of raw materials. The global nanoclay reinforcements market is anticipated to witness steady growth during the next few years due to rising demand for reinforced plastics in automobiles, aerospace, electronics, and construction industries. The nanoclay reinforcement market has expanded significantly during the past few years due to rising demand across companies manufacturing plastics. This trend is likely to continue during the forecast period. Rapid growth of these end-use industries is anticipated to further augment the nanoclay reinforcement market.

Request a Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5219

Production of MDF has been on a rise during the past few years owing to rapid growth of the furniture industry in Asia Pacific. This trend is estimated to boost the nanoclay reinforcement market during the next few years. Application of nanoclay reinforcement in liquid silicone rubber (LSR) is expected to witness strong growth during the next few years due to increasing demand for nanoclay-reinforced LSR in electrical, medical, automotive, and aerospace industries. Growth in application of nanoclay in reinforcement of polymer films, nonwovens, and fibers (including nylon 6, injection-molded polypropylene, and melt spun fiber) is projected to be one of the factors driving the market during the next few years.

North America has been the strongest market for nanoclay reinforcement in the past few years, followed by Europe and Asia Pacific. Increase in research and development activities related to nanomaterial and its technologies by major market players, which are supported by governmental initiatives, has proved to be a critical market driver in North American. Europe and Asia Pacific are anticipated to witness significant growth during the next few years due to rising demand for nanoclay reinforcement in end-use industries. Additionally, technological advancement along with increasing investment in nanotechnology research activities is expected to augment market growth in the near future. Development of bio-based nanoclay reinforcements such as soy-based unsaturated polyesters is likely to offer new opportunities for market growth during the next few years. Soy-based unsaturated polyester reinforcements exhibit much higher efficiencies.

Some of the major players in the nanoclay reinforcement market include Southern Clay Products Inc., Nanocor Inc., RTP Company, Crystal Nanoclay Pvt. Ltd., NanoClay and Technologies Inc, Nanoshel LLC among others.

Browse Report: http://www.transparencymarketresearch.com/nanoclay-reinforcement-market.html

Neural Stem & Progenitor Cell Products Market to Grab the Largest Market Share by 2019

Neurogenesis is a mechanism through which neurons are generated through neural stem cells or progenitor cells. Neurogenesis is active during pre natal development and is responsible for populating the brain with neurons. This significant process of neuron generation takes place in two parts of the brain namely subventricular zone and hippocampus. The rate of neurogenesis mechanism is mainly influenced by hormones such as testosterone. Neural stem cells are multipotent self renewing cells that are capable of generating phenotypes of the nervous system. These cells include astrocytes, oligodendrocytes and neurons. While, neural progenitor cells are the lines of stem cell division that usually undergo limited number of stem cell division invivo. Neural stem cells have been promising approach for the treatment of nervous system disorders. 

Factors such as increase in geriatric population, investment in R&D and improved understanding of the nature of neurologic diseases are driving the neural stem and progenitor cell products market growth globally. Since, aged population is more prone to brain disorders therefore; increase in geriatric population will likely increase the neural stem and progenitor cell products market worldwide. Additionally, as per the World Health Organization, by 2020 nearly 14.1% of the world population will suffer from neurologic disorders which would further lure manufacturers for the production of neural stem and progenitor cell products. Also as per the estimates approximately 5.4 million Americans were diagnosed with Alzheimer’s in 2012. Of these nearly one in eight people aged 65 years and above has Alzheimer’s disease. Additionally, 4% are under age 65, 44% are between age 75 to 84 and 46% are 85 years or older are diagnosed with Alzheimer’s. Hence, collectively all of the mentioned factors would increase the demand for neural stem cell products. 

The market for neural stem and progenitor stem cells can be categorized on the basis of applications and end users. Neurotoxicity testing, neural tissue engineering, personalized medicines, cellular therapies for the treatment of central nervous system conditions and drug target validation and testing and others are some of the major applications of the neural stem and progenitor cell products market. Academic labs, commercial labs, private labs and government laboratories are some of the major customers of the market. Development of neural stem cells products by the pharmaceutical sector represents a significant opportunity as development of new drugs is costly and bringing new drugs into the market is highly unpredictable.  

Some of the key players in the neural stem and progenitor cell products market are Stem Cells Technologies, EMD Millipore, Life Technologies Corporation, Thermo Fisher Scientific, Neural Stem, BD Biosciences, Lonza, NeuroGeneration, AlphaGenix, Inc. SA Biosciences, R&D Systems and others. Some of these manufacturers offer array of products for neural stem cell culture, media, supplements, growth factors and substrates. 

Increasing Research-driven Medical Treatment Practices Propelling Global Cell Culture Market

Cell culture is a process wherein eukaryotic or prokaryotic cells are produced outside their natural environment, in controlled laboratory conditions. Heavy research involved in developing the optimum environment for cells to survive in artificial surroundings has led cell culture to emerge as one of the key tools in cellular and molecular biology, carcinogenesis, and mutagenesis studies. Owing to this, the global cell culture market is poised to be worth US$11.3 bn by 2022, increasing from its 2013 valuation of US$6.1 bn at a CAGR of 7.10% therein.

Growing Medical Research for Treatment of Multiple Diseases Benefits Global Market

The medical research sector exhibits an exclusive demand for cell cultures, wherein studies pertaining to aging and metabolic cell processes, origination of mutations, and effect of new drugs on cells are some of the major research areas that are benefitting the cell culture market. Cancer detection, manufacture of biologics, and drug discovery are some of the other medical research areas that are triggering growth of this market. 

R&D initiatives taken by life sciences and biotechnology companies, and academic and industry collaborations for the advancement of cell culture apparatus and methodologies have been significantly favorable for the growth of the cell culture market. The use of cell and tissue cultures to study the cellular mechanisms and drug response for diseases such as Parkinson’s and Alzheimer’s has been notable for the development of the cell culture market.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405

Ethical Reasons Favor Cell Culture Methodologies sans Animal Components

The global cell culture market is divided on the basis of product type into two major segments, cell culture instruments and cell culture consumables. Cell culture consumables comprise the sera, media, and reagent segments. Out of these, it is the cell culture media segment that will be the fastest growing. The growing preference for animal-derived-component-free (ADCF) media, which ensures compliance with the ethical standards of medical research, is attributed to the phenomenal rise of this market segment.

By instrument, culture systems, pipetting systems, biosafety cabinets, incubators, roller bottle equipment, cryostorage equipment, and others are the segments of the cell culture market. Technological advancement in the design and function of cell culture instruments and increasing adoption of automated culture systems by manufacturers and researchers are promoting growth of the instruments product segment of the market. 

Outsourcing Practices Benefit Asia Pacific Cell Culture Market 

Apart from this, the global market for cell culture is divided into the regional segments of North America, Asia Pacific, Rest of the World (RoW), Europe, and Latin America. In 2013, North America stood as the largest regional market for cell cultures. Consistent research initiatives, which involve huge investments for the development of biologics and drugs, and the presence of top-notch biotechnology, pharmaceutical, and food and beverages companies are propelling the cell culture market in the region.

Asia Pacific is expected to be the fastest growing market for cell culture in the near future. Economic growth in China and India, in particular, has led to the development of modern research and manufacturing facilities, which is encouraging contract-based manufacturing and contract-based research outsourcing practices from the West.

In the Rest of the World and Latin America regions, increasing investments from both public and private agencies for life sciences research is driving the cell culture market. Improving healthcare infrastructure and governmental support for modern research practices are further aiding the growth of this market. 

Browse Full Global Cell Culture Market Report With Complete TOC @ http://www.transparencymarketresearch.com/cell-culture-market.html

Introduction of Cost-effective Video Telemedicine Technologies the Way Forward in Emerging Countries

Video telemedicine refers to a group of technologies and devices used to enable interaction between patients in remote areas and medical professionals. According to a recent UN survey, close to 50% of the global population still resides in rural areas. In spite of the rapid pace of urbanization in most developing countries around the world, a significant chunk of the global population is still devoid of qualified medical attention. This calls for an effective solution to enable access to healthcare to this populace, which has led to the rapid emergence of the telemedicine sector, and the global video telemedicine market in particular, in recent years.

According to a market analysis report recently published by leading market intelligence firm Transparency Market Research (TMR), the global video telemedicine market was worth just under US$560 mn in 2013. However, boosted by the urgent need for effective healthcare in rural areas, the market is expected to almost triple in size by 2020; TMR analysts predict that the video telemedicine market will expand to US$1.6 bn by 2020 at a CAGR of 16.50% therein.

Request a Sample Report: http://www.transparencymarketresearch.com/v-telemedicine-market.html

Improved Streamlining of Healthcare Dispensation Boosts Video Telemedicine Market

The major advantage offered by video telemedicine technologies is the increase in efficiency brought about in management of diseases. Since physically visiting a doctor can be taxing or in some cases impossible for rural patients, video telemedicine allows doctors to prescribe medication or therapies through a diagnosis over video conferencing. Apart from patients in remote areas, urban patient-doctor interactions are also benefited by video telemedicine; support for the same from insurance companies is also growing, promoting the acceptance of video telemedicine.

Apart from doctor-patient interactions, video telemedicine also comprises interactions between hospitals. Due to the ease of teleconferencing, video telemedicine allows for much easier and faster transfer of information than with conventional media. This allows top medical institutes to collaborate on medical research of various kinds, boosting the overall healthcare scenario.

Emerging Regions Promising for Global Video Telemedicine Market

Even though, at first glance, video telemedicine is most helpful in emerging regions, due to the relatively lower spread of urbanization, it is in regions such as North America and Europe that the video telemedicine market has the strongest growth prospects. The availability of high-tech medical infrastructure in North American and Western European countries has so far allowed video telemedicine to become a major healthcare technology. The North America market for video telemedicine, which led the global market in 2013, is expected to exhibit a stellar 15% CAGR from 2014 to 2020.

On the other hand, the lack of skilled personnel, advanced medical infrastructure, and significant government funding has restrained the video telemedicine market in regions such as Asia Pacific, Latin America, and Africa. Innovation of cost-effective video telemedicine technologies will help the market post strong figures in these regions. The growing support from APAC and Latin American governments for upgradation of nationalized healthcare infrastructure will also help the market for video telemedicine massively, as the increasing availability of high-speed mobile data in these regions is making availing video telemedicine easier than ever. Accordingly, the market for video telemedicine accessed through 4G technology is expected to expand the fastest in the aforementioned forecast period, with an 18% CAGR expected for the segment.

Browse Full Global Video Telemedicine Market Report With Complete TOC @ http://www.transparencymarketresearch.com/v-telemedicine-market.html

Future of U.S. Population Health Management Solutions

Population health management, or PHM, refers to the collection of overall data pertaining to patients from various health information technology resources. This data is then analyzed and collated into a patient record that is used for deciding the actions that care givers and governments should take to improve the overall quality of life. This meticulous service has garnered massive attention in recent years, especially in the U.S.

Market analysts, who had valued the U.S. population health management solutions market in the US$3.4 bn in 2014, are now expecting it to reach US$45.7 bn by 2023, at a CAGR of 23.9% from 2015 to 2023. The unique ability of population health management solutions to deliver promising outcomes at a lower cost will become the undercurrent for this remarkable growth.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=7412

Population Health Management: An Essential Tool for Health Management

Population health management solutions group the patients depending on their health conditions, risk factors, health status, and so on for minimizing untimely and expensive medical interventions involving emergency surgeries, long period of hospitalizations, and tough invasive procedures and tests.

The U.S. population health management solutions market is segmented on the basis of source, mode of operation, and end users. The sources, based on which this market is segmented, are software and service. By mode of operation, the market features the following segments: web-based, cloud-based, and premise-based. Furthermore, the end users of population health management solutions in the U.S. are government insurance providers, health care providers, private insurance providers, pharmaceutical companies, medical device organizations, and others such as diagnostic and imaging centers, employers, and research institutes.

Cloud-based Population Health Management Systems Segment to Drive Market’s Growth

Cloud-based population health management systems are expected to spearhead the U.S. population health management solutions market due to the integration of information technology in the healthcare sector. Furthermore, the population health management solutions services segment will also witness an upward trend in the coming years. However, the population health management solutions services segment will be led by the cloud-based population health management systems segment in the next few years.

Adoption of Healthcare IT Leads to Progress of Cloud-based Population Health Management Systems 

Cloud-based population health management systems will dominate the U.S. population health management solutions market due to the adoption of healthcare IT, springing pharmaceutical industry, and health insurance companies. This demand will also be fueled by a huge need for health management solutions across the U.S. The continuous help of these solutions to resolve the pressure on the U.S. health systems is also driving their adoption rate. Additionally, population health management tools also help in the management of vast databases to monitor and compare the overall clinical and financial results of population groups that are being studied.

Some of the important players in the U.S. population health management solutions market are Verisk Health, Conifer Health Solutions, Caradigm, NextGen Healthcare Information Systems, LLC, Health Catalyst, Healthagen LLC, International Business Machines (IBM) Corporation, Lumeris, Persivia, Premier, Inc., OptumHealth, Inc., The Advisory Board Company, ZeOmega, Inc, and Wellcentive, Inc. Most of these companies are constantly striving to devise innovative solutions to maintain a leading position in the highly competitive U.S. population health management solutions market.

Browse More: http://www.transparencymarketresearch.com/us-population-health-management-solutions-market.html